Meet ApplyKite Twin, the application assistant that learns with you
Meet your Twin, it learns with you
Your Twin learns with you
Launch week codes:30% off annual Pro20% off monthly Pro
Ends in00h00m00s
Ends in00h00m00s
David Hopkins
Has grant
Research Interests
Explore related searches
Recent Grants
Grant: Close
H2O Health Outcomes Observatory
Open Date: 2020-10-01
Close Date: 2025-09-30
Grant: Close
Developing and trialling the DAFNEplus (Dose for Adjustment for Normal Eating) intervention. A lifelong approach to promote effective self-management in adults with type 1 diabetes.
Open Date: 2016-03-01
Close Date: 2023-05-01
Grant: Close
Clinical Efficacy and Mechanistic Evaluation of Aflibercept for Proliferative Diabetic Retinopathy (acronym CLARITY)
Open Date: 2014-07-01
Close Date: 2017-06-30
Grant: Close
Improving Physical Health and Decreasing Cannabis Abuse in People With Severe Mental Illness
Open Date: 2007-08-01
Close Date: 2015-07-31
Articles (5)
Year:
2026
Year:
2025
This paper describes the protocol to test the feasibility of the S afe management of people with T ype 1 diabetes and EA ting D isorders stud Y (STEADY) intervention. STEADY is a novel complex intervention for people with type 1 diabetes and disordered eating (T1DE) of mild to moderate severity. The STEADY intervention integrates cognitive behavioural therapy (CBT) with diabetes education, and was developed using Experience‐Based Co‐Design. Methods The feasibility of STEADY will be tested using a randomised controlled feasibility trial. Forty adults with T1DE will be recruited and randomised into the STEADY intervention or treatment as usual control group. We will collect demographic, biomedical and psychometric data, routine glucose metrics and conduct the Structured Clinical Interview for DSM‐5. Participants randomised to the STEADY intervention will receive 12 STEADY therapy sessions with a diabetes specialist nurse trained in CBT, delivered via videoconference and an optional smartphone app. The main outcome at 6 months will be the feasibility of STEADY (recruitment, dropout rates, feasibility of delivery). The secondary outcomes are biomedical (HbA1c and glucose time in range) and psychological (person‐reported outcome measures in disordered eating, diabetes distress, depression and anxiety). A process evaluation will evaluate the fidelity, feasibility, acceptability and appropriateness of STEADY, and participant experiences. Ethics and dissemination The protocol was approved by the East of England—Essex Research Ethics Committee (21/EE/0235). Study findings will be shared with study participants and disseminated through peer‐reviewed publications and conference presentations.
Year:
2024
Year:
2024
Year:
2024
Collaborators (7)
Marietta Stadler
-
Amy Harrison
University College London
Mette Due-Christensen
Senior researcher
King's College London
Natalie Zaremba
King’s College London
Debbie Cooke
Reader in Long-Term Conditions, Health Psychologist
University of Surrey
Uffe Søholm
Deakin University
Dominic Ehrmann
-
Make your next move.
Prepare your application
Review drafts before you send them.